Daniel Schock Kusch finished his Doctoral thesis dealing with the development of novel markers for GFR measurement and their transcutaneous measurement at University of Heidelberg in 2008. He further participated in the development of that technique as Research Scientist at Innovation Lab GmbH, Heidelberg and Postdoc at University of Heidelberg and University of Applied Sciences Mannheim. In 2011, he became Co-founder of Mannheim Pharma & Diagnostics GmbH bringing the first system for transcutaneous measurement of kidney function for preclinical research to market. He is now Site Director at Medibeacon GmbH. Daniel Schock Kusch finished his Doctoral thesis dealing with the development of novel markers for GFR measurement and their transcutaneous measurement at University of Heidelberg in 2008. He further participated in the development of that technique as Research Scientist at Innovation Lab GmbH, Heidelberg and Postdoc at University of Heidelberg and University of Applied Sciences Mannheim. In 2011, he became Co-founder of Mannheim Pharma & Diagnostics GmbH bringing the first system for transcutaneous measurement of kidney function for preclinical research to market. He is now Site Director at Medibeacon GmbH.

Nephrology